Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
BMC Public Health ; 20(1): 848, 2020 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-32493337

RESUMO

BACKGROUND: Understanding of the relationship between multi-drug resistant tuberculosis and mental health is limited. With growing prevalence of multi-drug resistant tuberculosis, addressing mental ill-health has potential to improve treatment outcomes and well-being. In several low and middle-income contexts hospitalisation during treatment is common. Understanding of the impact on mental ill-health are required to inform interventions for patients with multi-drug resistant tuberculosis. Our aim was to identify the prevalence of comorbid depression among in-patients being treated for multi-drug resistant tuberculosis and to explore their experiences of comorbid disease and the care they received in a large specialist chest hospital in Dhaka, Bangladesh. METHODS: We conducted a quantitative cross-sectional survey among 150 multi-drug resistant tuberculosis in-patients (new cases = 34%, previously treated = 66%) in 2018. A psychiatrist assessed depression was assessed with the Structured Clinical Interview for Depression (SCID DSM-IV). We used multi-level modelling to identify associations with depression. Experience Bangladeshi researchers conducted qualitative interviews with 8 patients, 4 carers, 4 health professionals and reflective notes recorded. Qualitative data was analysed thematically. RESULTS: We found 33.8% (95% CI 26.7%; 41.7%) of patients were depressed. While more women were depressed 39.3% (95% CI 27.6%; 52.4%) than men 30.4% (95% CI 22%; 40.5%) this was not significant. After controlling for key variables only having one or more co-morbidity (adjusted odds ratio [AOR] = 2.88 [95% CI 1.13; 7.33]) and being a new rather than previously treated case (AOR = 2.33 [95% CI 1.06; 5.14]) were associated (positively) with depression. Qualitative data highlighted the isolation and despair felt by patients who described a service predominantly focused on providing medicines. Individual, familial, societal and health-care factors influenced resilience, nuanced by gender, socio-economic status and home location. CONCLUSIONS: Patients with multi-drug resistant tuberculosis are at high risk of depression, particularly those with co- and multi-morbidities. Screening for depression and psycho-social support should be integrated within routine TB services and provided throughout treatment.


Assuntos
Atitude Frente a Morte , Depressão/epidemiologia , Tuberculose Resistente a Múltiplos Medicamentos/psicologia , Adulto , Antituberculosos/uso terapêutico , Bangladesh , Comorbidade , Estudos Transversais , Depressão/microbiologia , Depressão/psicologia , Países em Desenvolvimento/estatística & dados numéricos , Feminino , Humanos , Renda , Masculino , Pessoa de Meia-Idade , Análise Multinível , Razão de Chances , Prevalência , Pesquisa Qualitativa , Apoio Social , Inquéritos e Questionários , Resultado do Tratamento , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico
2.
Mymensingh Med J ; 25(2): 366-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27277374

RESUMO

Bartter syndrome (BS) is a hereditary disease, with an autosomal recessive or autosomal dominant mode of transmission. It is characterized by salt wasting hypochloraemic, hypokalaemic metabolic alkalosis and hyperreninaemia with normal blood pressure. The primary defect is in the thick ascending limb of loop of Henle (TAL). Herein, we report a case that had typical features of BS like severe dehydration, severe hypokalaemia, metabolic alkalosis and failure to thrive but had normal aldosterone level which is very uncommon.


Assuntos
Aldosterona/sangue , Síndrome de Bartter/diagnóstico , Síndrome de Bartter/tratamento farmacológico , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Hipertensivos/administração & dosagem , Bangladesh , Síndrome de Bartter/metabolismo , Suplementos Nutricionais , Enalapril/administração & dosagem , Feminino , Hidratação , Humanos , Ibuprofeno/administração & dosagem , Lactente , Potássio/administração & dosagem , Resultado do Tratamento
3.
J Trop Pediatr ; 50(6): 357-8, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15537722

RESUMO

The study was conducted to investigate the micronutrient profile of human colostrum, and to assess the association of maternal characteristics to the micronutrients. Colostral concentrations of antioxidant vitamins E, C, and A were 21.34 +/- 8.47, 148.92 +/- 43.64, 0.79 +/- 0.42 micromol/l, respectively. The antioxidant minerals copper, zinc, and iron contents were 19.17 +/- 11.73, 63.69 +/- 12.82, 11.44 +/- 1.46 micromol/l, respectively. Maternal characteristics did not have any influence on the colostral micronutrients.


Assuntos
Colostro/química , Bem-Estar Materno , Micronutrientes/metabolismo , Minerais/metabolismo , Adolescente , Adulto , Ácido Ascórbico/análise , Ácido Ascórbico/metabolismo , Atitude Frente a Saúde , Bangladesh , Cromatografia Líquida de Alta Pressão , Estudos de Coortes , Cobre/análise , Cobre/metabolismo , Países em Desenvolvimento , Feminino , Humanos , Ferro/análise , Ferro/metabolismo , Micronutrientes/análise , Minerais/análise , Período Pós-Parto , Gravidez , Medição de Risco , Sensibilidade e Especificidade , Vitamina A/análise , Vitamina A/metabolismo , Vitamina E/análise , Vitamina E/metabolismo , Zinco/análise , Zinco/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA